Tagged with Korea

Korea Jongmoon Kim, CEO of ToolGen discusses the potential for their CRISPR technology to revolutionize not only therapy for genetic illnesses, but also agriculture. Kim explains his move from information technology to biotechnology and the importance of building international partnerships across the industry.   CRISPR simplifies some of the complex tasks…

Korea JungTae Park, senior managing director of KoBIA (Korea Biomedicine Industry Association), describes the achievements of the association as a bridge between industry and government. He also highlights the potential of the Korean biopharmaceutical industry to become a global leader in the field.   Our priority is to support the globalization…

Korea Jia Liu, CEO of DreamCIS, a Korean CRO, part of the Chinese company Tigermed, talks about her vision for DreamCIS to be “the CRO everybody wants to work with”. Liu assesses the changing environment for clinical research in Korea and offers her view on the successes and scope for improvement…

Korea Olive Healthcare is a startup developing wellness and medical devices services for the quantitative measurement of body composition, an integral part of the new healthcare paradigm based on prevention. Here, Dr. Sung-Ho Han, its CEO and founder together with Andrew Son, chief strategy officer, sheds light on the first two…

South Korea A Korean research team at Ulsan National Institute of Science and Technology (UNIST) have developed a cunning technology for treatments that attack cancer cells.   Treatments that travel through the body to deliver a cancer destroying substance are hindered by hundreds of proteins that stick to the drug delivery system…

Korea From Wednesday 31st October to Friday 2nd November, Seoul hosted the KoNECT-MFDS International conference, promoting South Korea’s clinical research capabilities on a global platform. The fourth of its kind, the conference was based around the main theme of embracing change in clinical research. The conference was organised by KoNECT –…

Korea Celltrion Healthcare, the marketing arm of the biopharmaceutical company Celltrion won a huge deal in France last Friday (2nd November 2018) with big tenders for Herzuma, a biosimilar of Roche’s blockbuster breast cancer treatment Herceptin.   Herzuma, with indications for positive metastatic breast cancer, early cancer, and metastatic gastric cancer…

Korea Korea is fast becoming a big player in the pharmaceutical industry, especially within the biotech arena. With 4% of the total pipelines in the world, the country is showing strong R&D capabilities and fierce ambitions for growth. Korea is now the 3rd largest pharma region in Asia, with a forecasted…

Korea Korean Pharma company, Hanmi has won orphan drug status this week from the US Food and Drug Administration (FDA) for HM43239, a drug for the treatment of acute myeloid leukaemia (AML).   The endorsement of FDA’s Orphan Drug Designation (ODD) — invented to smooth the development of therapies for life-threatening…

Korea According to data from the Ministry of Health and Welfare, South Korea’s exports of products in the healthcare sector surged 30.9 percent in the first half from last year. Exports of drugs, medical devices, and cosmetics amounted to $7.1 billion (7.8 trillion won) in the first half, up almost 31 percent…

Korea With a market value of USD 18.6 billion in 2013, Korea is ranked by IMS Health as the 14th largest pharma market in the world. Predicted to reach USD 24.3 billion by 2020, there is clearly a lot of room for Korea to grow. The following table outlines some of…

Korea The following table shows how Seoul has risen through the ranks of cities around the world to become the most competitive city for clinical trials of pharma products in 2012.